Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study

Study Overview
=================
Brief Summary
-----------------
This is a multicenter pilot study, proposed for cases and controls 3 departments in France. Cases are cured patients who have had prostate cancer for at least 10 years. Cookies are healthy subjects selected by lottery on voter list. Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician.

Detailed Description
-----------------
Volunteer subjects (cases and controls) are offered a consultation and assessment with an geriatrician. During this consultation, ADL, IADL and MMS questionnary will be completed. neurocognitif testing will be done.

Official Title
-----------------
Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study

Conditions
-----------------
Prostate Cancer Cured, Healthy Population Control

Intervention / Treatment
-----------------
* Other: geriatric assessment


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria for patients: Patients aged 75 years or more Patients with a personal history of prostate cancer with a diagnosis ≥ 10 years Patients who received curative treatment (surgery, radiotherapy,hormone therapy, brachytherapy, technical ablative) for localized prostate cancer Patients considered cured of prostate cancer (regardless of initial treatment) Patients with previously agreed to participate in a case-control study in the general population (study QALIPRO) as a case and volunteer to receive an assessment of geriatric Signature of consent Affiliation to a social security system Exclusion Criteria for patients: Patients under 75 years Patients with recurrent or metastatic Persons deprived of liberty or under guardianship Inclusion Criteria for control population: Male subjects Subjects of 75 years or more Subjects that do not have cancer or a history of cancer (except basal cell skin cancer) Subject has previously agreed to participate in a case-control study in the general population (study QALIPRO) as a voluntary witness and to benefit from a balance oncogeriatrics Subjects who gave their written consent to participate in the study

Ages Eligible for Study
-----------------
Minimum Age: 75 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: geriatric assessment<br>geriatric assessment | Other: geriatric assessment<br>* A single geriatric assessment with a geriatrician was proposed to patients and to control population.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| impact of treatments | The main objective of this study is to evaluate the impact of treatments and their effects on the autonomy of patients over 75 years have been treated and cured for prostate cancer. | 10 years after treatment for cancer prostate | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluate the anxiety of patients and controls | Evaluate the anxiety of patients and controls | 10 years after treatment for cancer prostate | 
| Assessing depression patients and controls | Assessing depression patients and controls | 10 years after treatments for cancer prostate | 
| Assess the nutritional status of patients and controls | Assess the nutritional status of patients and controls | 10 years after treatments for cancer prostate | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
prostate cancer cured, aged patients